LRRK2 and tauopathy: Of the 13 cases with PEP and unclassifiable tauopathy we identified 1 case with both LRRK2 G2019S mutation and a heterozygous variant in MAPT exon 4 (c.370C>G, p.Q124E) (Fig. 1).